US20070292364A1 - Method for measurably improving oral health - Google Patents

Method for measurably improving oral health Download PDF

Info

Publication number
US20070292364A1
US20070292364A1 US11/749,099 US74909907A US2007292364A1 US 20070292364 A1 US20070292364 A1 US 20070292364A1 US 74909907 A US74909907 A US 74909907A US 2007292364 A1 US2007292364 A1 US 2007292364A1
Authority
US
United States
Prior art keywords
composition
centipoise
viscosity
zinc
oral health
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/749,099
Inventor
Tim Clarot
Regina Miskewitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ZICARE LLC
Original Assignee
ZICARE LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ZICARE LLC filed Critical ZICARE LLC
Priority to US11/749,099 priority Critical patent/US20070292364A1/en
Assigned to MATRIXX ORAL CARE, LLC reassignment MATRIXX ORAL CARE, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CLAROT, TIM, MISKEWITZ, REGINA
Assigned to ZICARE, LLC reassignment ZICARE, LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: MATRIXX ORAL CARE, LLC
Publication of US20070292364A1 publication Critical patent/US20070292364A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365Hydroxycarboxylic acids; Ketocarboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/731Cellulose; Quaternized cellulose derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Definitions

  • the present invention generally relates to methods for measurably improving oral health. More particularly, the invention relates to techniques for measurably reducing an amount of plaque, tartar, gingivitis, periodontitis, and/or bleeding of the gums
  • Plaque can be defined as an organized, coherent, gel-like or mucoid material that includes microorganisms in an organic matrix derived from saliva and extracellular bacterial products such as glucans, fructans, enzymes, toxins, and acids. Plaque may also contain other cells, such as desquamated epithelial cells, and inorganic components, such as calcium and phosphate.
  • dental plaque is a bacterial accumulation. Generally transparent and sticky, plaque accumulates around the teeth at the cervical margin, and then grows apically.
  • plaque forms on a surface, the plaque resists removal, and usually can be removed only by mechanical means, such as, for example, by brushing and flossing the affected areas. If not removed, however, the presence of plaque can give rise to tartar formation, tooth decay, gingivitis, periodontitis, and other health problems.
  • Tartar is a hard, calcified plaque material that exhibits a yellowish or brownish color. Tartar forms as a result of minerals (e.g., those present in saliva and gum pockets) reacting with plaque material to form a rough calculus. Calculus generally arises from the nucleation of calcium phosphate, often in areas where the large salivary gland ducts secrete their saliva. As such, calculus can form on surfaces not covered by the oral mucosa (supragingival) or on surface located apical to the soft tissue margin of the gingiva (subgingival).
  • tartar buildup can be problematic in several regards.
  • the rough, porous surface of tartar serves as a breeding ground for additional bacteria, which can calcify and form additional tartar.
  • the bacteria growth from both plaque and tartar can, in turn, lead to tooth decay, gum disease, gingivitis, periodontitis, tooth loss, as well as systemic health problems.
  • Gingivitis is the beginning stage of periodontitis and is often caused by long-term effects of plaque and tartar buildup. Gingivitis is characterized by red, swollen gums. A periodontal probe will often measure about 3 to about 5 mm in depth into the space between the teeth and gums at the early stages of gingivitis. At this stage, gingivitis can often be reversed with proper treatment.
  • gingivitis will likely progress to advanced periodontitis.
  • plaque and tartar are typically present supragingival and subgingival and an infection has destroyed bone around a tooth.
  • a family of chronic inflammatory infections are affecting the supporting tissues of the dentition. Teeth often become loose, and the pocket depth may range between about 5 mm and about 8 mm at this stage.
  • Tartar can be particularly problematic because it is difficult to remove and because of its yellowish or brownish color.
  • tartar tends to absorb colors from other sources (e.g., coffee, tea, tobacco, smoke, red wine and the like), and thus the presence of tartar exacerbates cosmetic tooth coloration typically associated with such other sources.
  • Typical self-administered techniques for promoting oral health include brushing, flossing, and rinsing with a mouth rinse that typically includes an antimicrobial agent. Although such techniques may work relatively well at mitigating plaque buildup, such techniques are not thought to be effective at removing existing tartar from a surface. Furthermore, although flossing is thought to reduce plaque buildup, relatively few people in the general population floss as often as they should (at least once a day). In a recent study, only 27% of consumers said they flossed once a day.
  • the usual methods of preventing tartar buildup include brushing with a tartar control toothpaste. Although such toothpastes, if used regularly, may prevent additional buildup of tartar, the toothpastes are not thought to be effective at removing existing tartar from tooth and device surfaces.
  • Typical methods of removing existing tartar typically include scaling or root planing, both of which are performed by dentists or hygienists with the aid of specialized tools. Although these techniques work well, they are relatively expensive and time consuming.
  • the present invention provides a method for measurably improving oral health. More particularly, the invention provides techniques for using a composition, system, and kit.
  • the composition includes one or more active ingredients to measurably reduce an amount of plaque, tartar, gingivitis, including gum bleeding, and/or other periodontal disease
  • a system includes the composition and a container
  • a kit includes a plurality of systems.
  • the present invention provides a relatively inexpensive, safe technique for the measurable improvement of oral care indices, such as Loe and Silness Gingival Index (1963) (GI), the Turesky Modification (1970) of the Quiqley and Hein Plaque Index (PI), Volpe-Manhold Index for Calculus (1965) (V-MI).
  • GI Loe and Silness Gingival Index
  • PI Quiqley and Hein Plaque Index
  • V-MI Volpe-Manhold Index for Calculus (1965)
  • the method is relatively easy to use, does not require a visit to a dentist office, and does not damage the surface of tooth enamel.
  • a method for measurably improving oral health includes use of a system that includes a composition, having one or more active ingredients to measurably improve oral health, and a container for enclosing and applying the composition.
  • a system in accordance with one embodiment of the invention, includes a viscous composition including at least one active ingredient and a container configured to dispense the viscous composition.
  • the viscous composition is designed to maintain the active ingredient(s) in contact with a surface for an extended period of time.
  • Exemplary compositions have a viscosity greater than about 20,000 cp, preferably greater than about 30,000 cp, and more preferably greater than about 35,000 cp.
  • the viscosity of the compositions may range from about 20,000 to about 250,000 cp, preferably about 25,000 to about 100,000, and more preferably about 30,000 to about 50,000 cp.
  • Suitable active ingredients include cetylpyridinium chloride (CPC), zinc salts, other antimicrobial agents, and other ingredients known to improve (typically reduce) measurable oral health care indices.
  • the container encapsulates a single dose of the composition, and the system includes a plurality of containers and doses.
  • the container is configured to facilitate application of the composition to specific areas within an oral cavity.
  • the system is designed to improve one or more oral health indices selected from the group of GI, PI, and V-MI.
  • a system in accordance with another embodiment of the invention, includes a composition, having a plurality of active ingredients to measurably improve oral health, and a container to hold the composition.
  • the composition includes a carrier having a thickening agent, wherein the composition is configured to maintain the plurality of active ingredients in contact with a surface for an extended period of time.
  • Exemplary thickening agents suitable for use in the composition include hydroxyethylcellulose, and other pharmaceutically acceptable thickeners, and exemplary active ingredients include CPC, zinc salts, other antimicrobial agents, and similar agents known to reduce tartar or plaque or gingivitis.
  • the container encapsulates a single dose of the composition, and the system includes a plurality of containers and doses.
  • the container is configured to facilitate application of the composition to specific areas within an oral cavity.
  • the system is designed to improve one or more oral health indices selected from the group of GI, PI, and V-MI.
  • a system in accordance with a further embodiment of the invention, includes a composition, having one or more active ingredients to measurably improve oral health and a carrier including a thickening agent, and a container to hold the composition.
  • exemplary thickening agents suitable for use in the composition include hydroxyethylcellulose, glycerin, and other pharmaceutically acceptable thickeners, and exemplary active ingredients include CPC, zinc salts, other antimicrobial agents, and similar agents known to improve oral health.
  • a system includes a container that encapsulates a single dose of the composition.
  • the container encloses multiple doses.
  • compositions, system, and kit are designed to improve one or more oral health indices selected from the group of GI, PI, and V-MI.
  • a method includes dispensing a composition from a sealed container by rupturing the sealed container and applying a single dose of the composition directly to the surface.
  • the composition is applied after brushing, flossing, and/or rinsing, and is applied before extended rest or bedtime to allow the active ingredients to stay in contact with a surface for an extended period of time
  • FIG. 1 illustrates a perspective view of a dispensing device in accordance with exemplary embodiments of the invention
  • FIGS. 2A-2D illustrate, respectively, left view, front view, right view and a top view of an exemplary container in accordance with an exemplary embodiment of the invention.
  • the present invention provides a method to measurably improve oral health. More particularly, the invention provides a method for using a composition, system, and kit to measurably improve one or more oral health care indices such as GI, PI, and V-MI.
  • the method of the invention can be used to improve oral health of various animals, is particularly well suited for the treatment of humans.
  • the term “surface” includes any surface on which plaque, tartar, or gum disease may form.
  • Exemplary surfaces include teeth (both supragingival and subgingival), gums, and dental appliances such as bridges, crowns, fillings, braces, and the like.
  • the term “measurably improve” means a measurable difference between an amount measured without use of the system of the present invention and with or after use of the system. The measurements may be compared for the same surface (before and after) or between test and control groups.
  • a method for measurably improving oral health includes a use of a viscous composition, including an active ingredient.
  • the composition is designed to maintain the active ingredient in contact with a surface for an extended period of time to allow the active ingredient(s) to stay in contact with possibly affected areas on the surface.
  • Exemplary active ingredients suitable for use with systems of the invention include one or more of the following: cetylpyridinium chloride (CPC), dicalcium phosphate dehydrate, hydrogen peroxide, sanguinaria extract, sodium bicarbonate, sodium lauryl sulfate, sodium fluoride, stannous fluoride, sodium monofluorophosphate (MFP), zinc salts such as zinc chloride, zinc acetate, zinc citrate, zinc oxide and zinc gluconate, alkyl dimethyl amine oxide, alkyl dimethyl glycine, eucalyptol, menthol, methyl salicylate, thymol, sodium citrate, peppermint oil, sage oil, polymethylsiloxane, polxamer, and stannous pyrophosphate.
  • CPC cetylpyridinium chloride
  • dicalcium phosphate dehydrate hydrogen peroxide
  • sanguinaria extract sodium bicarbonate
  • sodium lauryl sulfate sodium fluoride
  • any agent which alone or in combination is able to prevent or alleviate the severity of problems associated with dentition may be utilized.
  • agents useful in reducing tooth hypersensitivity such as potassium nitrate, strontium chloride and/or the like
  • plaque and calculus reducing agents such as, for example, chlorhexidine, quaternary ammonium compounds (e.g. benzethonium chloride, domphen bromide, etc.), triclosan, herbal compounds (e.g. sanguinarine), stannous salts, complex phosphates (e.g., pyrophosphates), SLS (e.g. sodium lauryl sulfate), hydrogen peroxide, and/or the like.
  • an amount of the active ingredient for use within compositions suitable for uses with the invention varies in accordance with the dosage size and particular ingredient(s).
  • each active or actives selected will be used in a suitably effective amount, generally on the order of less than about 10 wt %, and more preferably 5 wt % or less.
  • An amount of active may also be desirably selected to be within government guidelines, such as guidelines by the Food and Drug Administration in the USA.
  • the active ingredient is present in an amount of about 0.001 wt % to about 1.5 wt %, within an amount of about 0.025 wt % to about 1.0 wt %, or even within an amount about 0.05 wt % to about 0.7 wt %. All percentages set forth herein are in weight percent of the total composition, unless otherwise indicated.
  • the active ingredient includes CPC.
  • the CPC is present in an amount of about 0.001% to about 1%, preferably about 0.01% to about 0.5%, and more preferably about 0.05% to about 0.25% or about 0.045% to about 0.1%.
  • the active ingredient includes zinc gluconate.
  • the zinc gluconate is present in an amount of about 0.001% to about 1.5%, preferably about 0.01% to about 1.0%, and more preferably about 0.05% to about 0.75%.
  • the composition includes a thickener to obtain the desired viscosity.
  • suitable thickening agents include substances which increase the viscosity of the composition, cause the composition to gel or coagulate, or the like, such as food-grade or pharmaceutical grade thickeners, including, for example, hydroxyethylcellulose.
  • hydroxyethylcellulose For example, hydroxyethylcellulose, hydroxypropyl methylcellulose, carrageenan, guar gum, methylcellulose, methyethylecellulose, acceptable non-ionic thickeners, and/or the like.
  • the thickener may be present in an amount of about 0.01 to about 10%, preferably about 0.1 to about 7%, and more preferably about 1% to about 5%.
  • the composition may also include a humectant such as a glycerin, which may be present in an amount of about 0.01% to about 15%, preferably about 0.1% to about 10%, and more preferably about 1 to about 7%.
  • a humectant such as a glycerin
  • the humectant may facilitate maintaining the composition in a liquid form and may help maintain a desired viscosity of the composition.
  • glycerin may facilitate maintaining one or more of the active ingredients in an ionic form and may facilitate the transport of the active ingredients through the composition.
  • the composition may also include a suitable diluent.
  • exemplary diluents for use with the present composition include water, alcohols, and oils.
  • the composition includes purified water in an amount of about 80% to about 99%, preferably about 85% to about 95%, and more preferably about 88% to about 92%.
  • the composition may also include sugar alcohols such as sorbitol that act as a sweetener and also as a humectant and/or emulsifier.
  • sugar alcohols such as sorbitol that act as a sweetener and also as a humectant and/or emulsifier.
  • sorbitol or other sugar alcohol is present in an amount of about 0.001% to about 0.5%, preferably about 0.01% to about 0.1%, and more preferably about 0.025% to about 0.075%.
  • the composition may also include a natural or artificial sweetener such as sucralose, ace-K, sodium, saccharin, aspartame, and/or the like, which, when included in the composition, is present in an amount of about 0.001% to about 1.5%, preferably about 0.01% to about 1%, and more preferably about 0.25% to about 0.75%.
  • a natural or artificial sweetener such as sucralose, ace-K, sodium, saccharin, aspartame, and/or the like, which, when included in the composition, is present in an amount of about 0.001% to about 1.5%, preferably about 0.01% to about 1%, and more preferably about 0.25% to about 0.75%.
  • Colorants may also be added to the composition as desired.
  • the composition includes colorants, such that when the composition is applied to or proximate the gingiva, the composition has a color indicative of healthy gingiva—i.e., the composition is pink in color. Providing a composition having a color indicative of healthy gingiva provides added incentive to users to continue using the composition, which in turn promotes measurable improvement in oral health indices.
  • Colorants may be present in any desired amount.
  • the colorants may include Red #33 and Red #40, available from Pylam in an amount of about 0.000001% to about 0.00018%, and more preferably about 0.00050% to about 0.00099.
  • the composition also optionally includes flavorants such as cinnamon oil, clove oil, mint flavorings, citrus flavorings, and the like.
  • flavorants such as cinnamon oil, clove oil, mint flavorings, citrus flavorings, and the like.
  • a composition includes cinnamon oil present in an about of about 0.001% to about 2%, preferably about 0.01% to about 1%, and more preferably about 0.1% to about 0.5%; and clove oil in an amount of about 0.001% to about 2%, preferably about 0.002% to about 1%, and more preferably about 0.003% to about 0.0075%.
  • the composition is configured to maintain the composition in contact with a surface for an extended period of time, which has several advantages over traditional compositions used to promote oral health.
  • the composition is both viscous and exhibits high micro adhesiveness.
  • the composition is both viscous and “sticks” to a surface to which it is applied.
  • the configuration of the composition permits relatively small amounts of the composition and consequently the active agent(s) to be used to effectively prevent or remove plaque and/or tartar buildup on a surface. This is advantageous, not only from an economic viewpoint, but it also reduces an amount of the composition that may be ingested.
  • the viscosity of the composition is suitably selected to facilitate easy delivery of the composition from its container, while also maintaining the composition in contact at particular areas within an oral cavity, such as the crevices within teeth and at the tooth gingival margin.
  • the viscosity is low enough to allow application of the composition to desired locations within the oral cavity.
  • compositions have a viscosity greater than about 20,000 cp, preferably greater than about 30,000 cp, and more preferably greater than about 35,000 cp.
  • the viscosity of compositions range from about 20,000 to about 250,000 cp, preferably about 25,000 to about 100,000, and more preferably about 30,000 to about 50,000 cp, and yet more preferably about 35,000 to about 45,000 cp.
  • the viscosity values as set forth herein are measured using a Brookfield, Model DV-II+ Pro viscometer, spindle # 6, 10 RPM for 90 seconds at 25 C.
  • a composition in accordance with another embodiment of the invention, includes one or more active ingredients in a carrier, which includes a thickening agent.
  • the active ingredient and thickening agent may include any one or more of the active ingredients and thickening agents noted above in the respective weight percents noted above.
  • the composition may also include any of the optional ingredients such as sweeteners, flavorants, and colorants as set forth herein.
  • a composition in accordance with this embodiment of the invention includes CPC and zinc gluconate as the active ingredients and hydroxyethylcellulose as the thickener.
  • the CPC is present in an amount of about 0.001% to about 1%, preferably about 0.01% to about 0.5%, and more preferably about 0.05% to about 0.25% or about 0.045% to about 0.1%
  • the zinc gluconate is present in an amount of about 0.001% to about 1.5%, preferably about 0.01% to about 1.0%, and more preferably about 0.05% to about 0.75%
  • the hydroxyethylcellulose is present in an amount of an amount of about 0.01 to about 10%, preferably about 0.1 to about 7%, and more preferably about 1% to about 5%.
  • a composition in accordance with another embodiment of the invention, includes multiple active ingredients.
  • the plurality of active ingredients may include any combination of the active ingredients noted above in the weight percents noted above.
  • the composition may also include any of the optional ingredients such as sweeteners, flavorants, and colorants as set forth herein.
  • the composition has a viscosity greater than about 20,000 cp, preferably greater than about 30,000 cp, and more preferably greater than about 35,000 cp.
  • the viscosity of compositions ranges from about 20,000 to about 250,000 cp, preferably about 25,000 to about 100,000, and more preferably about 30,000 to about 50,000 cp, and yet more preferably about 35,000 to about 45,000 cp.
  • the composition includes a thickening agent, which is present in an amount of an amount of about 0.01 to about 10%, preferably about 0.1 to about 7%, and more preferably about 1% to about 5%.
  • a composition in accordance with this embodiment of the invention includes CPC and zinc gluconate as the active ingredients.
  • the CPC is present in an amount of about 0.001% to about 1%, preferably about 0.01% to about 0.5%, and more preferably about 0.05% to about 0.25%; and the zinc gluconate is present in an amount of about 0.001% to about 1.5%, preferably about 0.01% to about 1.0%, and more preferably about 0.05% to about 0.75%.
  • a composition includes one or more active ingredients and a colorant indicative of healthy gingiva.
  • the color of the composition is more than merely decorative. It serves the function of encouraging those that use the product to continue to use the product because there is an immediate appearance, upon application of the composition, that the composition is promoting healthy gingiva.
  • FIG. 1 and FIGS. 2A-2D illustrate an enclosed, single-dose dispensing system 100 suitable for applying a composition 102 (e.g. a composition described herein) to a surface.
  • System 100 includes a resilient containment portion 104 and an applicator portion 106 .
  • Applicator portion 106 further includes a severed or scarred area 108 and a sealed end 110 .
  • Composition 102 is dispensed from system 100 by severing or rupturing a portion of device 100 (e.g., at or near scarred area 108 ) to expose composition 102 contained within system 100 .
  • Composition 102 is then expelled through applicator 106 to a desired area—e.g., a tooth gum margin of a user—by squeezing resilient portion 104 to cause the composition to flow from resilient portion 104 through applicator 106 .
  • system 100 may be configured to apply a composition to a specific area within an oral cavity.
  • applicator 106 may have a desirably small cross-section across applicator 106 .
  • a cross-sectional dimension, taken along line A-A is about 0.001′′ to about 0.2′′, preferably about 0.05′′ to about 0.01′′, and more preferably about 0.06′′ to about 0.09′′.
  • Resilient portion 104 is designed to fit comfortably between two fingers (e.g., a thumb and an index finger) of a user, such that the composition is expelled by pressing the two fingers, on opposite sides of portion 104 , together.
  • portion 104 has a cross-sectional dimension, taken along line B-B, of about 0.1′′ to about 2′′, preferably about 0.25′′ to about 1′′, and more preferably about 0.4′′ to about 0.6′′.
  • a single-dose size may vary in accordance with several factors, such as the particular active ingredient, the dilution of the composition, and the like.
  • Exemplary dose sizes for purpose of illustration range from about 0.5 mg to about 8 mg, preferably about 1 mg to about 7 mg, and more preferably about 2 mg to about 5 mg.
  • a method of measurably improving oral health includes applying a composition including one or more of the active ingredients described herein to a surface and maintaining the composition in contact with the surface for an extended period of time.
  • composition may be applied using a variety of methods such as with a swab, with a syringe, or using any other means capable of dispensing the composition and applying a thin film of gel on the teeth and gums.
  • the composition is selectively applied using system 100 . More particularly, composition 102 is applied though chute 106 to, e.g., a tooth/gingiva interface, such that the composition contacts both supragingival and subgingival areas where plaque and tartar is likely to form.
  • the method of this embodiment allows for direct, selective application of the composition to desired areas of a surface. Thus, less composition may be required to perform the task of measurably improving oral health, because the composition is not ubiquitously applied to an oral cavity.
  • a measurable difference of a gingivitis index (e.g., the Loe and Silness Gingival Index (1963)) is obtained by using the system of the present invention. More particularly, a measurable difference in the GI is obtained by applying a composition, e.g., from within the container, to an area (e.g., proximate an inflamed gum tissue, such as at the gum/tooth margin near the inflamed area).
  • a single dose of the composition is applied after brushing teeth, flossing between teeth, and/or rinsing an oral cavity, and is applied such that the composition remains in contact with the affected area for an extended period of time.
  • the composition can be applied at before an extended period of rest or bedtime to mitigate disruption of the composition/surface interface and to facilitate maintaining the composition in contact with the surface for an extended period.
  • a measurable difference of a plaque index e.g., the Turesky Modification (1970) of the Quiqley and Hein Plaque Index (PI) is obtained by using the method of the present invention.
  • the method is used as described above in connection with obtaining a measurable difference in the GI.
  • a measurable difference in a tartar index e.g., the Volpe-Manhold Index (V-MI)—is obtained by using the method of the present invention as described herein.
  • a “measurable difference” means a reduction in one or more of the selected indices of on the order of about 20% or more.
  • a measurable improvement in a stain index e.g., the Lobene Stain Index (SI)—is obtained using the system of the present invention.
  • compositions for use in accordance with the present invention may include the ingredients listed below as well as additional and/or alternative inert materials, preservatives, and other constituents typically found in compositions for promoting oral health.
  • inert materials and/or preservatives are listed, these ingredients are merely exemplary, and it is understood that other similar ingredients may be substituted for the materials listed in the examples below.
  • a pale light pink viscous gel, having a viscosity of about 40,000 cp, with cinnamon-clove characteristic odor and taste is formed by admixing the following ingredients in the amounts shown.
  • Example 1 A clinical study comparing the composition of Example 1 to a placebo and a commercial mouth rinse including CPC was conducted. Each group started with 25 people. At the conclusion of the 6 week test period, there was an observable/measurable difference in the quality and thickness of calculus in the group using the composition of Example 1, compared to the placebo and the mouth rinse. A significant disruption of calculus bridges or masses of calculus was observed in subjects using the composition of Example 1.
  • Example 1 A clinical study comparing the composition of Example 1 to a placebo and a mouth rinse including CPC was conducted. Each group started with 25 people. At the conclusion of a six week test period, there was an observable/measurable difference in the improvement of the GI for the group using the composition of Example 1, compared to the groups using the placebo and the rinse. The difference was statistically significant (p value ⁇ 0.05, based on ANCOVA results, adjusting for baseline value and multiple comparisons) in both absolute and percent improvement of GI between the groups.
  • Example 1 A clinical study comparing the composition of Example 1 to a placebo and a mouth rinse including CPC was conducted. Each group started with 25 people. At the conclusion of a six week test period, there was an observable/measurable difference in the improvement of the PI for the group using the composition of Example 1, compared to the groups using the placebo and the rinse.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

The present invention provides a method to measurably improve oral health. The method includes use of a composition, including one or more active ingredients to measurably improve oral health, a system including the composition and a container encapsulating the composition, and a kit including a plurality of systems. Each system is configured to apply the composition directly to a surface.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • This application claims the benefit of U.S. Provisional Patent Application Ser. No. 60/800,632, entitled SYSTEM FOR MEASURABLY IMPROVING ORAL HEALTH AND METHOD OF USING SAME, filed May 15, 2006.
  • FIELD OF INVENTION
  • The present invention generally relates to methods for measurably improving oral health. More particularly, the invention relates to techniques for measurably reducing an amount of plaque, tartar, gingivitis, periodontitis, and/or bleeding of the gums
  • BACKGROUND OF THE INVENTION
  • Unfortunately, poor oral health affects millions of people every year. Poor oral health may result in symptoms ranging bad breath, tooth decay, and tooth discoloration, to more serious health problems, such as gum disease, tooth loss, heart disease, stroke, poorly controlled diabetes and preterm labor.
  • The presence of dental plaque, or simply plaque, in an oral cavity can lead to such oral and general health problems. Plaque can be defined as an organized, coherent, gel-like or mucoid material that includes microorganisms in an organic matrix derived from saliva and extracellular bacterial products such as glucans, fructans, enzymes, toxins, and acids. Plaque may also contain other cells, such as desquamated epithelial cells, and inorganic components, such as calcium and phosphate. In general, dental plaque is a bacterial accumulation. Generally transparent and sticky, plaque accumulates around the teeth at the cervical margin, and then grows apically.
  • Once plaque forms on a surface, the plaque resists removal, and usually can be removed only by mechanical means, such as, for example, by brushing and flossing the affected areas. If not removed, however, the presence of plaque can give rise to tartar formation, tooth decay, gingivitis, periodontitis, and other health problems.
  • Tartar is a hard, calcified plaque material that exhibits a yellowish or brownish color. Tartar forms as a result of minerals (e.g., those present in saliva and gum pockets) reacting with plaque material to form a rough calculus. Calculus generally arises from the nucleation of calcium phosphate, often in areas where the large salivary gland ducts secrete their saliva. As such, calculus can form on surfaces not covered by the oral mucosa (supragingival) or on surface located apical to the soft tissue margin of the gingiva (subgingival).
  • Tartar adheres to hard surfaces such as enamel, roots, and dental devices, such as dentures, bridges, crowns, and the like, and is generally more difficult to remove than plaque. Brushing and flossing are normally not sufficient to remove tartar from a surface.
  • If left untreated, tartar buildup can be problematic in several regards. For example, the rough, porous surface of tartar serves as a breeding ground for additional bacteria, which can calcify and form additional tartar. The bacteria growth from both plaque and tartar can, in turn, lead to tooth decay, gum disease, gingivitis, periodontitis, tooth loss, as well as systemic health problems.
  • Gingivitis is the beginning stage of periodontitis and is often caused by long-term effects of plaque and tartar buildup. Gingivitis is characterized by red, swollen gums. A periodontal probe will often measure about 3 to about 5 mm in depth into the space between the teeth and gums at the early stages of gingivitis. At this stage, gingivitis can often be reversed with proper treatment.
  • Left untreated, gingivitis will likely progress to advanced periodontitis. At this stage of gum disease, plaque and tartar are typically present supragingival and subgingival and an infection has destroyed bone around a tooth. In general, at this stage, a family of chronic inflammatory infections are affecting the supporting tissues of the dentition. Teeth often become loose, and the pocket depth may range between about 5 mm and about 8 mm at this stage.
  • As noted above, in addition to the health concerns, plaque and tartar may give rise to cosmetic problems. Tartar can be particularly problematic because it is difficult to remove and because of its yellowish or brownish color. Moreover, because the surface of tartar is rough and porous, tartar tends to absorb colors from other sources (e.g., coffee, tea, tobacco, smoke, red wine and the like), and thus the presence of tartar exacerbates cosmetic tooth coloration typically associated with such other sources.
  • Typical self-administered techniques for promoting oral health include brushing, flossing, and rinsing with a mouth rinse that typically includes an antimicrobial agent. Although such techniques may work relatively well at mitigating plaque buildup, such techniques are not thought to be effective at removing existing tartar from a surface. Furthermore, although flossing is thought to reduce plaque buildup, relatively few people in the general population floss as often as they should (at least once a day). In a recent study, only 27% of consumers said they flossed once a day.
  • The usual methods of preventing tartar buildup include brushing with a tartar control toothpaste. Although such toothpastes, if used regularly, may prevent additional buildup of tartar, the toothpastes are not thought to be effective at removing existing tartar from tooth and device surfaces.
  • Typical methods of removing existing tartar typically include scaling or root planing, both of which are performed by dentists or hygienists with the aid of specialized tools. Although these techniques work well, they are relatively expensive and time consuming.
  • Accordingly, improved techniques for measurably reducing an amount of tartar, plaque, gingivitis, gum bleeding, periodontitis, and the like are desired.
  • SUMMARY OF THE INVENTION
  • The present invention provides a method for measurably improving oral health. More particularly, the invention provides techniques for using a composition, system, and kit. The composition includes one or more active ingredients to measurably reduce an amount of plaque, tartar, gingivitis, including gum bleeding, and/or other periodontal disease, a system includes the composition and a container, and a kit includes a plurality of systems.
  • While the ways in which the invention addresses the various drawbacks of known methods will be described in more detail below, in general, the present invention provides a relatively inexpensive, safe technique for the measurable improvement of oral care indices, such as Loe and Silness Gingival Index (1963) (GI), the Turesky Modification (1970) of the Quiqley and Hein Plaque Index (PI), Volpe-Manhold Index for Calculus (1965) (V-MI). The method is relatively easy to use, does not require a visit to a dentist office, and does not damage the surface of tooth enamel.
  • In accordance with various embodiments of the invention, a method for measurably improving oral health includes use of a system that includes a composition, having one or more active ingredients to measurably improve oral health, and a container for enclosing and applying the composition.
  • In accordance with one embodiment of the invention, a system includes a viscous composition including at least one active ingredient and a container configured to dispense the viscous composition. In accordance with various aspects of this embodiment, the viscous composition is designed to maintain the active ingredient(s) in contact with a surface for an extended period of time. Exemplary compositions have a viscosity greater than about 20,000 cp, preferably greater than about 30,000 cp, and more preferably greater than about 35,000 cp. The viscosity of the compositions may range from about 20,000 to about 250,000 cp, preferably about 25,000 to about 100,000, and more preferably about 30,000 to about 50,000 cp. Suitable active ingredients include cetylpyridinium chloride (CPC), zinc salts, other antimicrobial agents, and other ingredients known to improve (typically reduce) measurable oral health care indices. In accordance with additional aspects of this embodiment, the container encapsulates a single dose of the composition, and the system includes a plurality of containers and doses. In accordance with yet further aspects, the container is configured to facilitate application of the composition to specific areas within an oral cavity. In accordance with yet additional aspects of this embodiment, the system is designed to improve one or more oral health indices selected from the group of GI, PI, and V-MI.
  • In accordance with another embodiment of the invention, a system includes a composition, having a plurality of active ingredients to measurably improve oral health, and a container to hold the composition. In accordance with various aspects of this embodiment of the invention, the composition includes a carrier having a thickening agent, wherein the composition is configured to maintain the plurality of active ingredients in contact with a surface for an extended period of time. Exemplary thickening agents suitable for use in the composition include hydroxyethylcellulose, and other pharmaceutically acceptable thickeners, and exemplary active ingredients include CPC, zinc salts, other antimicrobial agents, and similar agents known to reduce tartar or plaque or gingivitis. In accordance with additional aspects of this embodiment, the container encapsulates a single dose of the composition, and the system includes a plurality of containers and doses. In accordance with yet further aspects, the container is configured to facilitate application of the composition to specific areas within an oral cavity. In accordance with yet additional aspects of this embodiment, the system is designed to improve one or more oral health indices selected from the group of GI, PI, and V-MI.
  • In accordance with a further embodiment of the invention, a system includes a composition, having one or more active ingredients to measurably improve oral health and a carrier including a thickening agent, and a container to hold the composition. Exemplary thickening agents suitable for use in the composition include hydroxyethylcellulose, glycerin, and other pharmaceutically acceptable thickeners, and exemplary active ingredients include CPC, zinc salts, other antimicrobial agents, and similar agents known to improve oral health.
  • In accordance with additional embodiments, a system includes a container that encapsulates a single dose of the composition. In accordance with alternative embodiments, the container encloses multiple doses.
  • In accordance with various additional embodiments, the composition, system, and kit are designed to improve one or more oral health indices selected from the group of GI, PI, and V-MI.
  • In accordance with various additional embodiments, a method includes dispensing a composition from a sealed container by rupturing the sealed container and applying a single dose of the composition directly to the surface. In accordance with another example, the composition is applied after brushing, flossing, and/or rinsing, and is applied before extended rest or bedtime to allow the active ingredients to stay in contact with a surface for an extended period of time
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The exemplary embodiments of the present invention will be described in connection with the appended drawing figures in which like numerals denote like elements and:
  • FIG. 1 illustrates a perspective view of a dispensing device in accordance with exemplary embodiments of the invention; and
  • FIGS. 2A-2D illustrate, respectively, left view, front view, right view and a top view of an exemplary container in accordance with an exemplary embodiment of the invention.
  • DETAILED DESCRIPTION
  • The present invention provides a method to measurably improve oral health. More particularly, the invention provides a method for using a composition, system, and kit to measurably improve one or more oral health care indices such as GI, PI, and V-MI. The method of the invention can be used to improve oral health of various animals, is particularly well suited for the treatment of humans.
  • As used throughout this application, the term “surface” includes any surface on which plaque, tartar, or gum disease may form. Exemplary surfaces include teeth (both supragingival and subgingival), gums, and dental appliances such as bridges, crowns, fillings, braces, and the like. Further, the term “measurably improve” means a measurable difference between an amount measured without use of the system of the present invention and with or after use of the system. The measurements may be compared for the same surface (before and after) or between test and control groups.
  • Viscous Composition
  • In accordance with exemplary embodiments of the invention, a method for measurably improving oral health includes a use of a viscous composition, including an active ingredient. As explained in greater detail below, the composition is designed to maintain the active ingredient in contact with a surface for an extended period of time to allow the active ingredient(s) to stay in contact with possibly affected areas on the surface.
  • Exemplary active ingredients suitable for use with systems of the invention include one or more of the following: cetylpyridinium chloride (CPC), dicalcium phosphate dehydrate, hydrogen peroxide, sanguinaria extract, sodium bicarbonate, sodium lauryl sulfate, sodium fluoride, stannous fluoride, sodium monofluorophosphate (MFP), zinc salts such as zinc chloride, zinc acetate, zinc citrate, zinc oxide and zinc gluconate, alkyl dimethyl amine oxide, alkyl dimethyl glycine, eucalyptol, menthol, methyl salicylate, thymol, sodium citrate, peppermint oil, sage oil, polymethylsiloxane, polxamer, and stannous pyrophosphate. Other now known or hereafter devised actives may also be used. For example, any agent, which alone or in combination is able to prevent or alleviate the severity of problems associated with dentition may be utilized. Such may include anti-caries agents and the like; agents useful in reducing tooth hypersensitivity, such as potassium nitrate, strontium chloride and/or the like; and/or plaque and calculus reducing agents, such as, for example, chlorhexidine, quaternary ammonium compounds (e.g. benzethonium chloride, domphen bromide, etc.), triclosan, herbal compounds (e.g. sanguinarine), stannous salts, complex phosphates (e.g., pyrophosphates), SLS (e.g. sodium lauryl sulfate), hydrogen peroxide, and/or the like.
  • An amount of the active ingredient for use within compositions suitable for uses with the invention varies in accordance with the dosage size and particular ingredient(s). In general, each active or actives selected will be used in a suitably effective amount, generally on the order of less than about 10 wt %, and more preferably 5 wt % or less. An amount of active may also be desirably selected to be within government guidelines, such as guidelines by the Food and Drug Administration in the USA. In particularly preferred compositions, the active ingredient is present in an amount of about 0.001 wt % to about 1.5 wt %, within an amount of about 0.025 wt % to about 1.0 wt %, or even within an amount about 0.05 wt % to about 0.7 wt %. All percentages set forth herein are in weight percent of the total composition, unless otherwise indicated.
  • In accordance with particular examples of this exemplary embodiment of the invention, the active ingredient includes CPC. In one case, the CPC is present in an amount of about 0.001% to about 1%, preferably about 0.01% to about 0.5%, and more preferably about 0.05% to about 0.25% or about 0.045% to about 0.1%.
  • In accordance with other examples, the active ingredient includes zinc gluconate. In one case, the zinc gluconate is present in an amount of about 0.001% to about 1.5%, preferably about 0.01% to about 1.0%, and more preferably about 0.05% to about 0.75%.
  • In accordance with further aspects, the composition includes a thickener to obtain the desired viscosity. Suitable thickening agents include substances which increase the viscosity of the composition, cause the composition to gel or coagulate, or the like, such as food-grade or pharmaceutical grade thickeners, including, for example, hydroxyethylcellulose. For example, hydroxyethylcellulose, hydroxypropyl methylcellulose, carrageenan, guar gum, methylcellulose, methyethylecellulose, acceptable non-ionic thickeners, and/or the like. The thickener may be present in an amount of about 0.01 to about 10%, preferably about 0.1 to about 7%, and more preferably about 1% to about 5%.
  • The composition may also include a humectant such a glycerin, which may be present in an amount of about 0.01% to about 15%, preferably about 0.1% to about 10%, and more preferably about 1 to about 7%. When used, the humectant may facilitate maintaining the composition in a liquid form and may help maintain a desired viscosity of the composition. In addition, glycerin may facilitate maintaining one or more of the active ingredients in an ionic form and may facilitate the transport of the active ingredients through the composition.
  • The composition may also include a suitable diluent. Exemplary diluents for use with the present composition include water, alcohols, and oils. In accordance with particular examples of the invention, the composition includes purified water in an amount of about 80% to about 99%, preferably about 85% to about 95%, and more preferably about 88% to about 92%.
  • The composition may also include sugar alcohols such as sorbitol that act as a sweetener and also as a humectant and/or emulsifier. When used, sorbitol or other sugar alcohol is present in an amount of about 0.001% to about 0.5%, preferably about 0.01% to about 0.1%, and more preferably about 0.025% to about 0.075%.
  • The composition may also include a natural or artificial sweetener such as sucralose, ace-K, sodium, saccharin, aspartame, and/or the like, which, when included in the composition, is present in an amount of about 0.001% to about 1.5%, preferably about 0.01% to about 1%, and more preferably about 0.25% to about 0.75%.
  • Colorants may also be added to the composition as desired. In accordance with various aspects, the composition includes colorants, such that when the composition is applied to or proximate the gingiva, the composition has a color indicative of healthy gingiva—i.e., the composition is pink in color. Providing a composition having a color indicative of healthy gingiva provides added incentive to users to continue using the composition, which in turn promotes measurable improvement in oral health indices.
  • Colorants may be present in any desired amount. By way of particular example, the colorants may include Red #33 and Red #40, available from Pylam in an amount of about 0.000001% to about 0.00018%, and more preferably about 0.00050% to about 0.00099.
  • The composition also optionally includes flavorants such as cinnamon oil, clove oil, mint flavorings, citrus flavorings, and the like. By way of one particular example, a composition includes cinnamon oil present in an about of about 0.001% to about 2%, preferably about 0.01% to about 1%, and more preferably about 0.1% to about 0.5%; and clove oil in an amount of about 0.001% to about 2%, preferably about 0.002% to about 1%, and more preferably about 0.003% to about 0.0075%.
  • Preferably, the composition is configured to maintain the composition in contact with a surface for an extended period of time, which has several advantages over traditional compositions used to promote oral health. In this regard, preferably the composition is both viscous and exhibits high micro adhesiveness. In accordance with one preferred embodiment, advantageously the composition is both viscous and “sticks” to a surface to which it is applied. In accordance with one aspect of a particularly preferred embodiment of the present invention, the configuration of the composition permits relatively small amounts of the composition and consequently the active agent(s) to be used to effectively prevent or remove plaque and/or tartar buildup on a surface. This is advantageous, not only from an economic viewpoint, but it also reduces an amount of the composition that may be ingested.
  • In general, the viscosity of the composition is suitably selected to facilitate easy delivery of the composition from its container, while also maintaining the composition in contact at particular areas within an oral cavity, such as the crevices within teeth and at the tooth gingival margin. In accordance with further embodiments of the invention, the viscosity is low enough to allow application of the composition to desired locations within the oral cavity.
  • Exemplary compositions have a viscosity greater than about 20,000 cp, preferably greater than about 30,000 cp, and more preferably greater than about 35,000 cp. By way of more particular examples, the viscosity of compositions range from about 20,000 to about 250,000 cp, preferably about 25,000 to about 100,000, and more preferably about 30,000 to about 50,000 cp, and yet more preferably about 35,000 to about 45,000 cp. The viscosity values as set forth herein are measured using a Brookfield, Model DV-II+ Pro viscometer, spindle # 6, 10 RPM for 90 seconds at 25 C.
  • Active Plus Thickener
  • In accordance with another embodiment of the invention, a composition includes one or more active ingredients in a carrier, which includes a thickening agent. The active ingredient and thickening agent may include any one or more of the active ingredients and thickening agents noted above in the respective weight percents noted above. The composition may also include any of the optional ingredients such as sweeteners, flavorants, and colorants as set forth herein.
  • By way of example, a composition in accordance with this embodiment of the invention includes CPC and zinc gluconate as the active ingredients and hydroxyethylcellulose as the thickener. In this case, the CPC is present in an amount of about 0.001% to about 1%, preferably about 0.01% to about 0.5%, and more preferably about 0.05% to about 0.25% or about 0.045% to about 0.1%; the zinc gluconate is present in an amount of about 0.001% to about 1.5%, preferably about 0.01% to about 1.0%, and more preferably about 0.05% to about 0.75%; and the hydroxyethylcellulose is present in an amount of an amount of about 0.01 to about 10%, preferably about 0.1 to about 7%, and more preferably about 1% to about 5%.
  • Multiple Active Ingredients
  • In accordance with another embodiment of the invention, a composition includes multiple active ingredients. The plurality of active ingredients may include any combination of the active ingredients noted above in the weight percents noted above. The composition may also include any of the optional ingredients such as sweeteners, flavorants, and colorants as set forth herein.
  • In accordance with one aspect of this embodiment, the composition has a viscosity greater than about 20,000 cp, preferably greater than about 30,000 cp, and more preferably greater than about 35,000 cp. By way of more particular examples, the viscosity of compositions ranges from about 20,000 to about 250,000 cp, preferably about 25,000 to about 100,000, and more preferably about 30,000 to about 50,000 cp, and yet more preferably about 35,000 to about 45,000 cp. In accordance with another embodiment, the composition includes a thickening agent, which is present in an amount of an amount of about 0.01 to about 10%, preferably about 0.1 to about 7%, and more preferably about 1% to about 5%.
  • By way of one particular example, a composition in accordance with this embodiment of the invention includes CPC and zinc gluconate as the active ingredients. In one case, the CPC is present in an amount of about 0.001% to about 1%, preferably about 0.01% to about 0.5%, and more preferably about 0.05% to about 0.25%; and the zinc gluconate is present in an amount of about 0.001% to about 1.5%, preferably about 0.01% to about 1.0%, and more preferably about 0.05% to about 0.75%.
  • Active Ingredient and Colorant
  • In accordance with this embodiment of the invention, a composition includes one or more active ingredients and a colorant indicative of healthy gingiva. In this case, the color of the composition is more than merely decorative. It serves the function of encouraging those that use the product to continue to use the product because there is an immediate appearance, upon application of the composition, that the composition is promoting healthy gingiva.
  • System
  • FIG. 1 and FIGS. 2A-2D illustrate an enclosed, single-dose dispensing system 100 suitable for applying a composition 102 (e.g. a composition described herein) to a surface. System 100 includes a resilient containment portion 104 and an applicator portion 106. Applicator portion 106 further includes a severed or scarred area 108 and a sealed end 110.
  • Composition 102 is dispensed from system 100 by severing or rupturing a portion of device 100 (e.g., at or near scarred area 108) to expose composition 102 contained within system 100. Composition 102 is then expelled through applicator 106 to a desired area—e.g., a tooth gum margin of a user—by squeezing resilient portion 104 to cause the composition to flow from resilient portion 104 through applicator 106.
  • As noted above, system 100 may be configured to apply a composition to a specific area within an oral cavity. In this case, applicator 106 may have a desirably small cross-section across applicator 106. In accordance with specific examples of the present invention, a cross-sectional dimension, taken along line A-A, is about 0.001″ to about 0.2″, preferably about 0.05″ to about 0.01″, and more preferably about 0.06″ to about 0.09″.
  • Resilient portion 104 is designed to fit comfortably between two fingers (e.g., a thumb and an index finger) of a user, such that the composition is expelled by pressing the two fingers, on opposite sides of portion 104, together. In accordance with various examples of the invention, portion 104 has a cross-sectional dimension, taken along line B-B, of about 0.1″ to about 2″, preferably about 0.25″ to about 1″, and more preferably about 0.4″ to about 0.6″.
  • A single-dose size may vary in accordance with several factors, such as the particular active ingredient, the dilution of the composition, and the like. Exemplary dose sizes for purpose of illustration range from about 0.5 mg to about 8 mg, preferably about 1 mg to about 7 mg, and more preferably about 2 mg to about 5 mg.
  • Method of Measurably Improving Oral Health
  • A method of measurably improving oral health includes applying a composition including one or more of the active ingredients described herein to a surface and maintaining the composition in contact with the surface for an extended period of time.
  • The composition may be applied using a variety of methods such as with a swab, with a syringe, or using any other means capable of dispensing the composition and applying a thin film of gel on the teeth and gums. In accordance with various aspects of this embodiment, the composition is selectively applied using system 100. More particularly, composition 102 is applied though chute 106 to, e.g., a tooth/gingiva interface, such that the composition contacts both supragingival and subgingival areas where plaque and tartar is likely to form. Unlike most methods of promoting oral health, the method of this embodiment allows for direct, selective application of the composition to desired areas of a surface. Thus, less composition may be required to perform the task of measurably improving oral health, because the composition is not ubiquitously applied to an oral cavity.
  • In accordance with one aspect of this embodiment, a measurable difference of a gingivitis index (e.g., the Loe and Silness Gingival Index (1963)) is obtained by using the system of the present invention. More particularly, a measurable difference in the GI is obtained by applying a composition, e.g., from within the container, to an area (e.g., proximate an inflamed gum tissue, such as at the gum/tooth margin near the inflamed area). In accordance with various aspects of this embodiment, a single dose of the composition is applied after brushing teeth, flossing between teeth, and/or rinsing an oral cavity, and is applied such that the composition remains in contact with the affected area for an extended period of time. By way of particular example, the composition can be applied at before an extended period of rest or bedtime to mitigate disruption of the composition/surface interface and to facilitate maintaining the composition in contact with the surface for an extended period.
  • In accordance with another aspect, a measurable difference of a plaque index, e.g., the Turesky Modification (1970) of the Quiqley and Hein Plaque Index (PI) is obtained by using the method of the present invention.
  • In accordance with another aspect, the method is used as described above in connection with obtaining a measurable difference in the GI.
  • In accordance with yet a further aspect of this exemplary embodiment, a measurable difference in a tartar index—e.g., the Volpe-Manhold Index (V-MI)—is obtained by using the method of the present invention as described herein. As used herein, a “measurable difference” means a reduction in one or more of the selected indices of on the order of about 20% or more. In accordance with yet another embodiment a measurable improvement in a stain index—e.g., the Lobene Stain Index (SI)—is obtained using the system of the present invention.
  • SPECIFIC EXAMPLES
  • The following non-limiting examples illustrate measurable improvements in various indices using the method in accordance with various embodiments of the invention. These example are merely illustrative, and it is not intended that the invention be limited to the examples. Compositions for use in accordance with the present invention may include the ingredients listed below as well as additional and/or alternative inert materials, preservatives, and other constituents typically found in compositions for promoting oral health. In the case where exemplary inert materials and/or preservatives are listed, these ingredients are merely exemplary, and it is understood that other similar ingredients may be substituted for the materials listed in the examples below.
  • Example 1 Reduction in V-MI
  • A pale light pink viscous gel, having a viscosity of about 40,000 cp, with cinnamon-clove characteristic odor and taste is formed by admixing the following ingredients in the amounts shown.
    TABLE 1
    Exemplary
    Ingredient Supplier Weight % Wt % Range
    Purified Water Copacker 91.603  80-99
    Glycerin USP Acme-Hardesty 5.000  0.01-15
    HEC 250 HX Hercules-Aqualon 2.000  0.01-10
    Sorbitol Roquette 0.050 0.001-0.5
    Sucralose Tate & Lyle 0.400 0.001-1.5
    Cetylpyridinium Dastech 0.100 0.001-1  
    Chloride
    Zinc Gluconate American Ingredients/ 0.592 0.001-1.5
    USP Pharmachem Inc.
    Cinnamon (Oil) Berje 0.250 0.001-2  
    Clove (Oil) Berje 0.005 0.001-2  
    Red #40 (1% sol.) Pylam 0.00099 0.000001-0.001 
  • A clinical study comparing the composition of Example 1 to a placebo and a commercial mouth rinse including CPC was conducted. Each group started with 25 people. At the conclusion of the 6 week test period, there was an observable/measurable difference in the quality and thickness of calculus in the group using the composition of Example 1, compared to the placebo and the mouth rinse. A significant disruption of calculus bridges or masses of calculus was observed in subjects using the composition of Example 1.
  • A visibly noticeable amount of tartar was removed from the surface of the teeth after the six-week period.
  • Example 2 Reduction in GI
  • A clinical study comparing the composition of Example 1 to a placebo and a mouth rinse including CPC was conducted. Each group started with 25 people. At the conclusion of a six week test period, there was an observable/measurable difference in the improvement of the GI for the group using the composition of Example 1, compared to the groups using the placebo and the rinse. The difference was statistically significant (p value≦0.05, based on ANCOVA results, adjusting for baseline value and multiple comparisons) in both absolute and percent improvement of GI between the groups.
  • Example 3 Reduction in PI
  • A clinical study comparing the composition of Example 1 to a placebo and a mouth rinse including CPC was conducted. Each group started with 25 people. At the conclusion of a six week test period, there was an observable/measurable difference in the improvement of the PI for the group using the composition of Example 1, compared to the groups using the placebo and the rinse.
  • Although exemplary embodiments of the present invention are set forth herein, it should be appreciated that the invention is not so limited. Various modifications, variations, and enhancements in composition and method set forth herein may be made without departing from the spirit and scope of the present invention.

Claims (20)

1. A method to measurably improve an oral health index comprising:
a. providing at least one system, the at least one system including a composition within a container wherein the composition comprises an active ingredient for measurably improving oral health; and
b. applying the composition to a surface within an oral cavity;
wherein the oral health index comprises at least one of a gingival index, a plaque index and a calculus index and wherein the viscosity of the composition is greater than about 20,000 centipoise.
2. The method of claim 1, wherein the viscosity of the composition is about 20,000 centipoise to about 250,000 centipoise.
3. The method of claim 2, wherein the viscosity of the composition is about 25,000 to about 100,000 centipoise.
4. The method of claim 3, wherein the viscosity of the composition is about 30,000 to about 50,000 centipoise.
5. The method of claim 1, wherein the active ingredient comprises at least one of cetylpyridinium chloride, dicalcium phosphate dehydrate, hydrogen peroxide, sanguinaria extract, sodium bicarbonate, sodium lauryl sulfate, stannous fluoride, zinc salts such as zinc chloride, zinc acetate, zinc citrate, and zinc gluconate, alkyl dimethyl amine oxide, alkyl dimethyl glycine, eucalyptol, menthol, methyl salicylate, thymol, sodium citrate, peppermint oil, sage oil, polymethylsiloxane, polxamer, and stannous pyrophosphate.
6. The method of claim 1, further comprising a kit including a plurality of systems.
7. A method to measurably reduce existing tartar comprising:
a. providing a system including a composition within a container, the composition including an active ingredient and a thickening agent for measurably reducing existing tartar and the container including a resilient vial and a spout for targeted delivery of the composition; and
b. applying the composition to a surface within an oral cavity.
8. The method of claim 7, wherein the viscosity of the composition is about 20,000 centipoise to about 250,000 centipoise.
9. The method of claim 8, wherein the viscosity of the composition is about 25,000 to about 100,000 centipoise.
10. The method of claim 9, wherein the viscosity of the composition is about 30,000 to about 50,000 centipoise.
11. The method of claim 7, wherein the active ingredient comprises at least one of cetylpyridinium chloride, dicalcium phosphate dehydrate, hydrogen peroxide, sanguinaria extract, sodium bicarbonate, sodium lauryl sulfate, stannous fluoride, zinc salts, alkyl dimethyl amine oxide, alkyl dimethyl glycine, eucalyptol, menthol, methyl salicylate, thymol, sodium citrate, peppermint oil, sage oil, polymethylsiloxane, polxamer, and stannous pyrophosphate.
12. The method of claim 7, wherein the thickening agent comprises at least one of hydroxyethylcellulose, hydroxypropyl methylcellulose, carrageenan, guar gum, methylcellulose, and methyethylecellulose.
13. The method of claim 12 wherein the thickening agent is present in an amount of about 0.01 wt % to about 10 wt %.
14. The method of claim 13, wherein the thickening agent is present in an amount of about 0.1 wt % to about 7 wt %.
15. The method of claim 14, wherein the thickening agent is present in an amount of about 1 wt % to about 5 wt %.
16. A method to measurably improve an oral health index comprising the steps of:
a. providing at least one system, the at least one system including a composition within a container, wherein the composition comprises a plurality of active ingredients for measurably improving oral health and a thickener;
b. applying the composition to a surface within an oral cavity; and
c. maintaining the composition in contact with the surface for an extended period of time;
wherein the oral health index comprises at least one of a gingival index, a plaque index and a calculus index.
17. The method of claim 11, wherein the viscosity of the composition is greater than about 20,000 centipoise.
18. The method of claim 13, wherein the viscosity of the composition is about 25,000 to about 100,000 centipoise.
19. The method of claim 14, wherein the viscosity of the composition is about 30,000 to about 50,000 centipoise.
20. The method of claim 16, wherein the active ingredient comprises at least one of cetylpyridinium chloride, dicalcium phosphate dehydrate, hydrogen peroxide, sanguinaria extract, sodium bicarbonate, sodium lauryl sulfate, stannous fluoride, zinc salts such as zinc chloride, zinc acetate, zinc citrate, and zinc gluconate, alkyl dimethyl amine oxide, alkyl dimethyl glycine, eucalyptol, menthol, methyl salicylate, thymol, sodium citrate, peppermint oil, sage oil, polymethylsiloxane, polxamer, and stannous pyrophosphate.
US11/749,099 2006-05-15 2007-05-15 Method for measurably improving oral health Abandoned US20070292364A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US11/749,099 US20070292364A1 (en) 2006-05-15 2007-05-15 Method for measurably improving oral health

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80063206P 2006-05-15 2006-05-15
US11/749,099 US20070292364A1 (en) 2006-05-15 2007-05-15 Method for measurably improving oral health

Publications (1)

Publication Number Publication Date
US20070292364A1 true US20070292364A1 (en) 2007-12-20

Family

ID=38617294

Family Applications (5)

Application Number Title Priority Date Filing Date
US11/748,657 Abandoned US20070292362A1 (en) 2006-05-15 2007-05-15 Method for orthodontia care
US12/300,995 Active 2029-09-07 US9072673B2 (en) 2006-05-15 2007-05-15 Method for measurably improving oral health
US11/748,661 Abandoned US20070292363A1 (en) 2006-05-15 2007-05-15 Method for prevention and treatment of periodontal disease
US11/749,099 Abandoned US20070292364A1 (en) 2006-05-15 2007-05-15 Method for measurably improving oral health
US11/749,138 Abandoned US20070292370A1 (en) 2006-05-15 2007-05-15 Method for improving oral health

Family Applications Before (3)

Application Number Title Priority Date Filing Date
US11/748,657 Abandoned US20070292362A1 (en) 2006-05-15 2007-05-15 Method for orthodontia care
US12/300,995 Active 2029-09-07 US9072673B2 (en) 2006-05-15 2007-05-15 Method for measurably improving oral health
US11/748,661 Abandoned US20070292363A1 (en) 2006-05-15 2007-05-15 Method for prevention and treatment of periodontal disease

Family Applications After (1)

Application Number Title Priority Date Filing Date
US11/749,138 Abandoned US20070292370A1 (en) 2006-05-15 2007-05-15 Method for improving oral health

Country Status (2)

Country Link
US (5) US20070292362A1 (en)
WO (1) WO2007134335A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010009119A2 (en) 2008-07-15 2010-01-21 Basf Catalysts Llc Tooth whitening compositions and methods
US20100196512A1 (en) 2009-02-04 2010-08-05 Basf Catalyst Llc Treatment of Non-Oral Biological Tissue with Chlorine Dioxide
DK2418945T3 (en) 2009-04-15 2019-02-25 Bmg Pharma S P A Mineral salt-sulfonic acid compositions and methods of use
CA2825137A1 (en) * 2010-01-22 2011-07-28 University Of Louisville Research Foundation, Inc Methods of treating or preventing periodontitis and diseases associated with periodontitis
SG185628A1 (en) * 2010-06-30 2012-12-28 Colgate Palmolive Co Oral health index
EP2600833B1 (en) 2010-08-07 2017-03-08 The Research Foundation for The State University of New York Oral compositions comprising a zinc compound and an anti-microbial agent
JP6574150B2 (en) * 2016-08-10 2019-09-11 小林製薬株式会社 Oral composition
MX2020014311A (en) 2018-06-25 2021-04-28 Triumph Pharmaceuticals Inc Methods of inhibiting microbial infections using zinc-containing compositions.
US10927397B2 (en) 2018-10-16 2021-02-23 Sterilex, Llc Compositions, devices and methods for detecting biofilms
BR112022016384A2 (en) 2020-02-18 2022-10-11 Sunstar Americas Inc ORAL CARE COMPOSITION

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134511A (en) * 1976-11-27 1979-01-16 Stella Kg Werner Deussen Container with frangible seal
US4941520A (en) * 1986-05-16 1990-07-17 Dowzall Martin E Formulating pasty materials
US5755572A (en) * 1992-08-10 1998-05-26 Novadent Ltd. Oral hygiene irrigator syringe bulb
US5948390A (en) * 1997-08-25 1999-09-07 Pfizer Inc. Stable zinc/citrate/CPC oral rinse formulations
US6095813A (en) * 1999-06-14 2000-08-01 3M Innovative Properties Company Method for applying a dental composition to tooth structure
US6355229B1 (en) * 2001-06-27 2002-03-12 Church & Dwight Co., Inc. Oral composition containing cetylpyridinium chloride and guar hydroxypropyltrimonium chloride and method of using the same
US20030003059A1 (en) * 2001-04-03 2003-01-02 Frederic Dana Dentifrice compositions
US20040131559A1 (en) * 2002-11-04 2004-07-08 Hauck Douglas J. Oral disease prevention and treatment
US20050026107A1 (en) * 2003-07-28 2005-02-03 Britesmile Development, Inc. Therapeutic responsive dental gel composition

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB337383A (en) 1929-07-26 1930-10-27 Josua Gabriel Paulin Improvements in mouth and tooth cleansing apparatus
US2029483A (en) 1934-08-15 1936-02-04 James J Holland Water syringe
US3199510A (en) 1962-08-27 1965-08-10 William W Sinai Hygienic dental device
US4242323A (en) 1979-08-22 1980-12-30 Vlock D G Plaque inhibiting oral composition
US4664906A (en) * 1984-08-30 1987-05-12 Johnson & Johnson Products Inc. Oral compositions
US4814163A (en) * 1986-03-10 1989-03-21 Colgate-Palmolive Company Solid antitartar mouth deodorant
DE8632961U1 (en) 1986-12-09 1987-01-29 Stella-KG. Werner Deussen, 6228 Eltville Container with breakable closure
GB2210264A (en) 1987-10-02 1989-06-07 Richardson Vicks Ltd Antigingival/antiplaque compositions
US4966312A (en) 1988-12-06 1990-10-30 Waring Donald A Disposable oral liquid measure dispenser
WO1990015592A1 (en) 1989-06-12 1990-12-27 Patrick John Shanahan Anti-plaque dentifrice
US5094845A (en) * 1991-03-04 1992-03-10 David G. Vlock Oral compositions containing zinc gluconate complexes
US5246371A (en) * 1992-08-31 1993-09-21 Ultradent Products, Inc. Method and apparatus for delivery of highly filled, thixotropic sealant to teeth
US5578295A (en) 1995-04-28 1996-11-26 The Procter & Gamble Company Oral care compositions comprising certain substituted diphenyl ethers
ATE287673T1 (en) * 1995-06-07 2005-02-15 Southern Biosystems Inc CONTROLLED FEED SYSTEM WITH A HIGH VISCOSITY LIQUID
US6425704B2 (en) 2000-01-07 2002-07-30 Closure Medical Corporation Adhesive applicators with improved applicator tips
US6723305B2 (en) * 2002-03-04 2004-04-20 Colgate Palmolive Company Anti-microbial breath freshening mouthrinse
EP1393710A1 (en) * 2002-08-21 2004-03-03 The Procter & Gamble Company A method of applying an oral composition
US6861049B2 (en) * 2002-11-12 2005-03-01 Douglas B. Harwood Aqueous slurries useful for cleaning the tongue and throat
WO2004071321A2 (en) 2003-02-05 2004-08-26 Fmc Corporation Toothpaste compositions with reduced abrasivity
US6932603B2 (en) 2003-08-08 2005-08-23 Johnny Steve Han Interproximal squirt brush
US7306121B2 (en) 2005-03-21 2007-12-11 Hygiene-Technik Inc. Gooseneck squeezable dispenser

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134511A (en) * 1976-11-27 1979-01-16 Stella Kg Werner Deussen Container with frangible seal
US4941520A (en) * 1986-05-16 1990-07-17 Dowzall Martin E Formulating pasty materials
US5755572A (en) * 1992-08-10 1998-05-26 Novadent Ltd. Oral hygiene irrigator syringe bulb
US5948390A (en) * 1997-08-25 1999-09-07 Pfizer Inc. Stable zinc/citrate/CPC oral rinse formulations
US6095813A (en) * 1999-06-14 2000-08-01 3M Innovative Properties Company Method for applying a dental composition to tooth structure
US20030003059A1 (en) * 2001-04-03 2003-01-02 Frederic Dana Dentifrice compositions
US6355229B1 (en) * 2001-06-27 2002-03-12 Church & Dwight Co., Inc. Oral composition containing cetylpyridinium chloride and guar hydroxypropyltrimonium chloride and method of using the same
US20040131559A1 (en) * 2002-11-04 2004-07-08 Hauck Douglas J. Oral disease prevention and treatment
US20050026107A1 (en) * 2003-07-28 2005-02-03 Britesmile Development, Inc. Therapeutic responsive dental gel composition

Also Published As

Publication number Publication date
WO2007134335A3 (en) 2008-01-24
US9072673B2 (en) 2015-07-07
WO2007134335A2 (en) 2007-11-22
US20070292363A1 (en) 2007-12-20
US20090257963A1 (en) 2009-10-15
US20070292370A1 (en) 2007-12-20
US20070292362A1 (en) 2007-12-20

Similar Documents

Publication Publication Date Title
US20070292364A1 (en) Method for measurably improving oral health
Malhotra et al. Comparison of the effectiveness of a commercially available herbal mouthrinse with chlorhexidine gluconate at the clinical and patient level
Keijser et al. Comparison of 2 commercially available chlorhexidine mouthrinses
CN110996891B (en) Gel comprising chlorhexidine
Farah et al. Mouthwashes
US8303938B2 (en) Anti-calculus dental composition
US20070292369A1 (en) Method for preventing and reducing tartar buildup
US20070292366A1 (en) System, kit and method for promoting and maintaining oral health
Maden et al. The Efficacy of Xylitol, Xylitol-Probiotic and Fluoride Dentifrices in Plaque Reduction and Gingival Inflammation in Children: A Randomised Controlled Clinical Trial.
US20070098650A1 (en) Dental formulation
US20070292365A1 (en) Method of mitigating and disrupting tartar buildup
US8871183B2 (en) Composition for promoting and maintaining oral health
US20070292367A1 (en) Method and system for facilitating and maintaining oral health through prescribed applications of oral compositions
US20230000738A1 (en) Oral Care Compositions and Methods
BR112021008102A2 (en) oral mucosa carrier and protector
JP2548265B2 (en) Oral hygiene medicine
US20070292372A1 (en) Gel composition for improving oral health, system including the composition, and methods of using and forming same
US20070292531A1 (en) Composition for oral use and methods for application of same
Pader Dental products
US20210015734A1 (en) Oral Care Products and Methods
US20070292368A1 (en) Oral care composition
US20240342074A1 (en) Teeth whitening products
ITMI20000710A1 (en) NEW FORMULATIONS FOR THE REMOVAL OF DENTAL PLATE AND TARTAR
Llena et al. Anticalculus efficacy of a new dentifrice.
Janeshin et al. Effect of an Iranian Toothpaste Compared with a Commonly Used Foreign-Made Toothpasteon Plaque Index of 9-to 12-Year-Old children: a clinical trial

Legal Events

Date Code Title Description
AS Assignment

Owner name: MATRIXX ORAL CARE, LLC, ARIZONA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:CLAROT, TIM;MISKEWITZ, REGINA;REEL/FRAME:019821/0063;SIGNING DATES FROM 20070801 TO 20070806

Owner name: ZICARE, LLC, ARIZONA

Free format text: CHANGE OF NAME;ASSIGNOR:MATRIXX ORAL CARE, LLC;REEL/FRAME:019821/0720

Effective date: 20070815

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION